Clinical Trial Update: Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating fludarabine-based conditioning for severe aplastic anemia has completed recruitment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Fludarabine-based conditioning regimen (fludarabine)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Anemia, Aplastic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-10-04